Waymo's venture into New York City isn't merely an exploration; it's a strategic conquest of the ultimate urban labyrinth. As the competition thins, particularly with Cruise's setbacks, Waymo finds itself...
As the US and EU contemplate a trade framework with a 10% baseline tariff, fascinating dynamics unfold with carve-outs for spirits and aircraft. This strategic manoeuvre seems aimed at mitigating...
The proposed 10% US tariff on European Union goods may seem a step towards peace, but lurking "caveats" could derail the tranquillity. Industries like European automotive could bear the brunt,...
The US Dollar encountered its steepest first-half decline since 1973, fuelled by expectations of a Federal Reserve pivot and buoyant global economic growth. However, the dollar roared back in the...
A spate of insider share purchases at Immuneering has sparked intrigue, suggesting internal confidence amidst its precarious financial backdrop. With its lead drug, IMM-1-104, potentially stirring hope for RAS-mutant cancer...
Oscar Health has achieved its first profitable quarter, signalling a significant shift from cash-burning to profitable operations. However, it faces the looming challenge of potential subsidy expiration under the Affordable...
Carvana's journey from the edge of insolvency to profitability is a quintessential turnaround tale, intriguing both investors and sceptics. In just two years, this online used-car retailer has not only...
Amidst whispers on future US trade policies, recent insights suggest new universal tariffs may not stack upon existing ones, significantly softening their economic impact. For industries reliant on Chinese imports,...
In a resounding pivot, Core Scientific has shifted from potential takeover target to strategic partner, securing 12-year contracts with CoreWeave projected to yield over $3.5 billion. This transformative move diversifies...
The freshly proposed tariffs suggest a nuanced strategy, aiming at economic vulnerabilities across Asia and Africa. Investors should anticipate shifts in supply chains, with beneficiaries likely to emerge in Mexico...
